concerned wrote:
concerned wrote:
Shouldn't people only be getting it done in a phase I trial or something?
drsclafani wrote:
we do not need phase one trials for angioplasty of the jugular vein. that is nonsense fed to you by someone who appears to know nothing about venous angioplasty.
Well, you could note the "or something" as I am not a medical professional and I don't know all the subtle nuances of the terminology, however, I am trying to learn.
I just meant that in treating MS, it should be clearly demonstrated to the medical world at large that it is a viable MS treatment and enough to justify the hysteria and paranoia that has engulfed this grassroots movement. (If you want to argue that point I have treasure troves of messages insinuating that I'm an employee of a big pharma firm.)
Emotional pleas are all fine and dandy, but inadequate in satiating the desires of the scientific community, namely, a desire for proof. So please just clearly demonstrate it in a reputable journal how CCSVI causes or is a major co-morbidity factor in MS and how "Liberation" could alleviate MS symptoms and we can end all this suspense.
I'm certain that there will be a plethora of papers published on CCSVI. However, if someone has a demonstrable problem with their veins, then why should they not be allowed to get them treated?
In addition, where is the "proof" that MS is an autoimmune disease? Nearly all of the journal articles that I've read over the years state that MS is believed to be of autoimmune origin. Moreover, the following statement was just published in a review paper in the journal Neurology...
Although MS is viewed by many to be an autoimmune disease, the evidence supporting this concept is elusive. There remains no evidence, for example, that Igs identified within the CSF of patients with MS are directed against any myelin proteins.
NHE